P626 SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease

BACKGROUND: Patients with Inflammatory Bowel Disease (IBD) suffer from a chronic illness and many of them need immunosuppressive therapy throughout the course of the disease. Consequently, COVID-19 pandemic has caused uncertainty about the possible increased risk of suffering SARS-CoV-2 infection th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Crohns Colitis
Main Authors: García Mateo, S, Martínez-Domínguez, S J, Aso Gonzalvo, M C, Gargallo-Puyuelo, C J, Gallego Llera, B, Arroyo Villarino, M T, Laredo de la Torre, V, Nocito Colon, M M L, Lario Quilez, L, Refaie, E, Latre Santos, M, Gomollón García, F
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Poster Presentations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8194830/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab076.746
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares